Who are ZuraPrep without 70% IPA's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Iodine povidone, ChloraPrep One-Step, A (Chloraprep), Iodophor 0.7% and IPA 74% w/w, Antiseptic Wash, Iodophor (10% povidone-iodine).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/zuraprep-without-70-ipa.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

ZuraPrep without 70% IPA — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ZuraPrep without 70% IPA (ZuraPrep without 70% IPA) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antiseptic. Area: Surgical site infection prevention.

phase 3 Topical antiseptic Surgical site infection prevention Small molecule Live · refreshed every 30 min

Target snapshot

ZuraPrep without 70% IPA (ZuraPrep without 70% IPA) — Zurex Pharma, Inc.. ZuraPrep without 70% IPA is a topical antiseptic solution that helps prevent surgical site infections by reducing microbial load.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
ZuraPrep without 70% IPA TARGET	ZuraPrep without 70% IPA	Zurex Pharma, Inc.	phase 3	Topical antiseptic
Iodine povidone	Iodine povidone	Montefiore Medical Center	marketed	Topical antiseptic/disinfectant
ChloraPrep One-Step	ChloraPrep One-Step	C. R. Bard	marketed	Topical antiseptic
A (Chloraprep)	A (Chloraprep)	Instituto de Investigacion Sanitaria La Fe	marketed	Topical antiseptic	Bacterial cell membrane and proteins
Iodophor 0.7% and IPA 74% w/w	Iodophor 0.7% and IPA 74% w/w	Johns Hopkins University	marketed	Topical antiseptic/disinfectant
Antiseptic Wash	Antiseptic Wash	Johnson & Johnson Consumer Inc. (J&JCI)	marketed	Topical antiseptic
Iodophor (10% povidone-iodine)	Iodophor (10% povidone-iodine)	University of California, Irvine	marketed	Topical antiseptic/disinfectant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antiseptic class)

Poitiers University Hospital · 2 drugs in this class
Professional Disposables International, Inc. · 2 drugs in this class
Central DuPage Hospital · 2 drugs in this class
Solventum US LLC · 1 drug in this class
University of British Columbia · 1 drug in this class
University of Iowa · 1 drug in this class
C. R. Bard · 1 drug in this class
Zurex Pharma, Inc. · 1 drug in this class
Instituto de Investigacion Sanitaria La Fe · 1 drug in this class
Johnson & Johnson Consumer Inc. (J&JCI) · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ZuraPrep without 70% IPA — Competitive Intelligence Brief. https://druglandscape.com/ci/zuraprep-without-70-ipa. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing